Latest Expert Opinions

Signal
Opinion
Expert
TOP PICK
TOP PICK
November 19, 2019
It's spent time building a base and is ready to move higher. Yes, headline news is a risk. He believes it will move higher. (Analysts’ price target is $150.39)
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
November 19, 2019
It's spent time building a base and is ready to move higher. Yes, headline news is a risk. He believes it will move higher. (Analysts’ price target is $150.39)
BUY
BUY
November 19, 2019
Had a head and shoulders with a big run then big drop. The momentum is over. Its believers are now back to own it. Will be news driven. The risk is to the upside.
Show full opinionHide full opinion
Had a head and shoulders with a big run then big drop. The momentum is over. Its believers are now back to own it. Will be news driven. The risk is to the upside.
BUY
BUY
November 19, 2019
These lab stocks are news-driven and could drop on a negative headline. Each time it pulled back, it bounced back higher. The chart looks good here and he would buy.
Show full opinionHide full opinion
IDEXX Laboratories (IDXX-Q)
November 19, 2019
These lab stocks are news-driven and could drop on a negative headline. Each time it pulled back, it bounced back higher. The chart looks good here and he would buy.